Newsfeeds - Spark Newswire

3 minute read

Gristone bio Highlights Presentations At American Association For Cancer Research On Its Neoantigen Vaccine Design, Delivery

Today, 6:12 AM

-- Translational immunology data and cassette design capabilities enabled development of an optimized, KRAS-specific version of “off-the-shelf” vaccine candidate now in Phase 2 (SLATE-KRAS) -- -- GRANITE

GRTS

11 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 6:12 AM

On Friday, 166 companies set new 52-week lows.

AAON

2 minute read

Earnings

Gritstone Oncology Earnings Perspective: Return On Capital Employed

By Benzinga Insights

Today, 6:12 AM

Gritstone Oncology (NASDAQ:GRTS) brought in sales totaling $3.06 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 5.87%, resulting in a loss of $29.77 million.

GRTS

1 minute read

HC Wainwright & Co. Maintains Buy on Gritstone Bio, Lowers Price Target to $15

By Benzinga Newsdesk

Today, 6:12 AM

HC Wainwright & Co. analyst Sean Lee maintains Gritstone Bio (NASDAQ:GRTS) with a Buy and lowers the price target from $24 to $15.

GRTS

4 minute read

Gritstone Announces 3 Presentations For Tumor-Specific Neoantigen Oncology Programs, Granite And Slate, At The 2022 AACR Annual Meeting

By Steve Krause

Today, 6:12 AM

Gritstone Announces Three Presentations for Tumor-Specific Neoantigen (TSNA) Oncology Programs, GRANITE and SLATE, at the 2022 AACR Annual Meeting -- Oral presentation toGritstone Announces Three Presentations for Tumor-Specific Neoantigen (TSNA) Oncology Programs, GRANITE and SLATE, at the 2022 AACR Annual Meeting

GRTS

32 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 6:12 AM

On Monday, 524 stocks hit new 52-week lows.

AAL

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 6:12 AM

Gainers Quidel (NASDAQ:QDEL) shares increased by 7.4% to $106.2 during Friday's after-market session. The market value of their outstanding shares is at $4.4 billion.

ARDS

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 6:12 AM

Gainers Epizyme (NASDAQ:EPZM) shares increased by 7.3% to $1.32 during Tuesday's after-market session. Epizyme's trading volume hit 240.6K shares by close, accounting for 10.7% of its average volume over the last 100 days. The company's market cap stands at $140.0 million.

AGRX